|
Life SciCon is a consultant to the Biotech industry and to institutional investors. The specific resources and expertise of the Company provide our clients with the highest degree of service.We are a private Company, independent from Banks and Investment Houses. With a focus on Equity Research, Corporate Finance & Capital Markets for start-up and Small-/MidCap situations, especially growth Companies, we support management and stakeholders of such Companies in executing their growth and financial strategy. As advisors and coordinators we evaluate companies, issue prospectuses and facilitate equity and debt placements. We administer bidding processes and professionally execute them in the capital markets. We also provide fairness opinions and conduct impairment tests.Based on the market expertise of our professional partners we consult companies to obtain financing in the Private Equity and public markets. It is the natural conflict of interests in the capital markets arena that we understand to moderate based on a fair representation of assets and resources. As a partner of the Company’s management we try to objectively match interests of banks, issuers, and the investment community. We secure the quality of our work with high professional standards and a profound experience pertaining to partners and employees. Our consulting practices are governed by the DVFA (German Association of Financial Analysts and Asset Managers).
Primary business focus:
· Providing fairness opinions, corporate appraisals and conducting due diligence;
· Funding of growth companies in all phases of the business cycle;
· Primary and Secondary market placements, Arrangement of block trades;
· Auctioning processes (defining strategy and execution);
· Structuring and arranging acquisitions and divestitures.
Secondary business focus:
· Corporate Strategy relating to financial and marketing concepts;
· Investor Relations pertaining to corporate funding / placement
;· Corporate Planning, Financial Planning, Business Development;
· Design of Stock Option Plans and Corporate Incentive Plans.
|
|
|
